185 results on '"Boschetti, Mara"'
Search Results
2. An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
3. Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up
4. Prevalence of diabetic striatopathy and predictive role of glycated hemoglobin level
5. Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood
6. Long-Term Efficacy and Safety of Nutritional and Pharmacological Strategies for Obesity.
7. "Present and future of immunotherapy in Neuroendocrine Tumors"
8. Ianus Bifrons: The Two Faces of Metformin
9. Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients
10. L’ipovitaminosi D nell’anziano: indicazioni al trattamento
11. Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD
12. Effects of magnesium supplementation on post-thyroidectomy hypocalcemia: a prospective single-center study.
13. Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly
14. Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells
15. Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms
16. Fisiopatologia dell’ipovitaminosi D nell’anziano
17. One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients
18. Undescended Testis: Prevalence and Clinical Features
19. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins
20. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?
21. Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients
22. Pituitary image: pituicytoma
23. Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiency
24. Conventional and Nuclear Medicine Imaging in Ectopic Cushingʼs Syndrome: A Systematic Review
25. Effect of environment on growth: Auxological and hormonal parameters in African and Italian children
26. Effects of magnesium supplementation on post-thyroidectomy hypocalcemia: a prospective single-center study
27. Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience
28. GH Replacement in the Elderly: Is It Worth It?
29. Psychological distress in patients with hypocortisolism during mass quarantine for Covid-19 epidemic in Italy
30. Octreotide-Resistant Acromegaly: Challenges and Solutions
31. Diabetes Secondary to Neuroendocrine Gastroenteropancreatic Tumors
32. Interactions between vitamin D and IGF-I: from physiology to clinical practice
33. Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients
34. Somatostatin receptor pathophysiology in the neuroendocrine system
35. Undescended Testis: Prevalence and Clinical Features
36. Emerging drugs for the treatment of acromegaly
37. Initial Staging of Lymphoma With Octreotide and Other Receptor Imaging Agents
38. Characterization of the IGF system in 15 patients with Alström syndrome
39. Neuroendocrine-Immune Interactions: The Role of Cortistatin/Somatostatin System
40. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system
41. Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients
42. One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients
43. The undescended testis. Prevalence and clinical features
44. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?
45. Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor
46. Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study
47. Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders
48. Nuove potenziali applicazioni degli analoghi della somatostatina
49. Pituitary image: pituicytoma
50. In memory of Francesco Maria Minuto
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.